Transmodulation of cell surface regulatory molecules via ectodomain shedding

Biological Chemistry

Volumn 383, Issue 1, 2002, Pages 69-83

  Sbarba, Persio Dello ^a   Rovida, Elisabetta ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Convertase; Down modulation; Down regulation; Endoprotease; Metalloprotease

Indexed keywords

CELL ADHESION MOLECULE; CELL RECEPTOR; LIGAND; LYSOSOME ENZYME; MEMBRANE PROTEIN; METALLOPROTEINASE; PROTEIN KINASE C; PROTEINASE; REGULATOR PROTEIN; CELL SURFACE RECEPTOR;

APOPTOSIS; CARCINOGENESIS; CELL DEGENERATION; CELL FUNCTION; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; DENSITY; DOWN REGULATION; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL ADHESION MOLECULES; ENDOPEPTIDASES; HUMANS; MEMBRANE PROTEINS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 0036122955     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2002.007     Document Type: Review

References (161)

1. Proteolytic cleavage of atrial natriuretic factor receptor in bovine adrenal membranes by endogenous metalloendopeptidase. Effects on guanylate cyclase activity and ligand-binding specificity
2. Cellular redistribution of protein tyrosine phosphatases LAR and PTPsigma by inducible proteolytic processing
3. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins
4. Shedding of growth hormone-binding protein is inhibited by hydroxamic acid-based protease inhibitors: Proposed mechanism of activation of growth hormone-binding protein secretase
5. TNF-α converting enzyme (TACE) is inhibited by TIMP-3
6. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors
7. Role of the juxtamembrane domains of the transforming growth factor-precursor and the β-amyloid precursor protein in regulated ectodomain shedding
8. Transforming growth factor-α and β-amyloid precursor protein share a secretory mechanism
9. + cells
10. Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells
11. Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: Role for interreceptor interaction in kinase regulation
12. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes
13. CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes
14. Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. Induction of cleavage of L-selectin via CD16
15. Metalloproteinase-mediated release of the ectodomain of L1 adhesion molecule
16. Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor
17. Modulation of PKC δ tyrosine phosphorylation and activity in salivary and PC-12 cells by Src kinases
18. Human neutrophils release the Leu-8 lymphnode homing receptor during cell activation
19. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
20. Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor
21. Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but does not induce receptor shedding
22. Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor
23. Increased level of serum HLA class I antigens in patients with systemic lupus in patients with systemic lupus erythematosus. Correlation with disease activity
24. The carboxyl-terminal valine residues of proTGF α are required for its efficient maturation and intracellular routing
25. Cell surface ectodomain cleavage of human amphiregulin precursor is sensitive to a metalloprotease inhibitor. Release of a predominant N-glycosylated 43-kDa soluble form
26. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner
27. TrkA receptor ectodomain cleavage generates a tyrosine-phosphorylated cell-associated fragment
28. T lymphocytes conditioned with Interferon induce membrane and soluble VCAM on human brain endothelial cells
29. T lymphocytes conditioned with Interferon beta induce membrane and soluble VCAM on human brain endothelial cells
30. N-syndecan: Structure and function of a transmembrane heparan sulfate proteoglycan
31. Cleavage of the epidermal growth factor receptor by a membrane-bound leupeptin-sensitive protease active in nonionic detergent lysates of senescent but not young human diploid fibroblasts
32. 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts
33. Mannose 6-phosphate/insulin-like growth factor II-binding proteins in human serum and urine. Their relation to the mannose 6-phosphate/insulin-like growth factor II receptor
34. Release of soluble transferrin receptor from the surface of human leukemic HL60 cells
35. Shedding of human thyrotropin receptor ectodomain. Involvement of a matrix metalloprotease
36. A mechanism of TNFR type II (75 kDa) 'shedding' in macrophages
37. Specific induction of 80-kDa tumor necrosis factor receptor shedding in T lymphocytes involves the cytoplasmic domain and phosphorylation
38. A metalloprotease inhibitor blocks shedding of the 80-kDa TNF receptor and TNF processing in T lymphocytes
39. Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage
40. Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro
41. Released form of CNTF receptor α component as a soluble mediator of CNTF responses
42. Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide
43. Regulation of ICAM-3 (CD50) membrane expression on human neutrophils through a proteolytic shedding mechanism
44. Apical enrichment of human EGF precursor in Madin-Darby canine kidney cells involves preferential basolateral ectodomain cleavage sensitive to a metalloprotease inhibitor
45. Structural requirements for the ectodomain cleavage of human cell surface macrophage colony-stimulating factor
46. Stimulation of cleavage of membrane proteins by calmodulin inhibitors
47. Involvement of a metalloprotease in low-affinity nerve growth factor receptor truncation: Inhibition of truncation in vitro and in vivo
48. Stimulation-induced down-regulation of tumor necrosis factor-converting enzyme
49. Ligand and protein kinase-C down-modulate the colony-stimulating factor-1 receptor by independent mechanisms
50. Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family
51. Proteolytic release of membrane-bound angiotensin-converting enzyme: Role of the juxtamembrane stalk sequence
52. Increased shedding of angiotensin-converting enzyme by a mutation identified in the stalk region
53. Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis
54. The conversion of the human membrane-associated folate binding protein (folate receptor) to the soluble folate binding protein by a membrane-associated metalloprotease
55. Ectodomain shedding of TGF-α and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades
56. Shedding of the lymphocyte L-Selectin adhesion molecule is inhibited by a hydroxamic acid-based protease inhibitor
57. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase
58. Shedding of adhesion receptors from the surface of activated platelets
59. Pneumocystis carinii enhances soluble mannose receptor production by macrophages
60. Soluble CD21 (sCD21) forms biologically active complexes with CD23: SCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells
61. Function of an axonal chemoattractant modulated by metalloprotease activity
62. Suramin modulates cellular levels of hepatocyte growth factor receptor by inducing shedding of a soluble form
63. TACE (ADAM17) mediates the cleavage and shedding of Fractalkine (CX3CL1)
64. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading
65. Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors
66. Down-regulation of L-selectin expression in neutrophils by nonsteroidal anti-inflammatory drugs: Role of intracellular ATP concentration
67. Adenosine triphosphate-induced shedding of CD23 and L-Selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases
68. Phorbol ester- and growth factor-induced growth hormone (GH) receptor proteolysis and GH-binding protein shedding: Relationship to GH receptor down-regulation
69. Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells
70. Shedding and enrichment of the glycolipid-anchored complement lysis inhibitor protectin (CD59) into milk fat globules
71. Ectodomain shedding, translocation and synthesis of SorLA are stimulated by its ligand head activator
72. Structural characterization of the circulating soluble FGF receptors reveals multiple isoforms generated by secretion and ectodomain shedding
73. CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-α converting enzyme
74. Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc γ RIII (CD16-II)
75. Soluble receptors in human disease
76. Cleavage of β-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: Evidence for a role for caspases and metalloproteinases
77. Okadaic acid induces down-modulation and shedding of tumor necrosis factor receptors. Comparison with another tumor promoter, phorbol ester
78. Membrane protein secretases
79. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: Evidence for proteolysis of cell-surface molecules
80. PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics
81. A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKC δ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor
82. Enhanced murine macrophage TNF receptor shedding by cytosine-guanine sequences in oligodeoxynucleotides
83. Shedding of the soluble IL-6 receptor is triggered by Ca2+ mobilization, while basal release is predominantly the product of differential mRNA splicing in THP-1 cells
84. Human dendritic cells shed a functional, soluble form of the mannose receptor
85. Soluble human interleukin-4 receptor is produced by activated T cells under the control of metalloproteinases
86. Calmodulin regulates L-selectin adhesion molecule expression and function through a protease-dependent mechanism
87. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration
88. Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias
89. Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: Implication for angiogenesis in fibrin matrices
90. Use of a mutant cell line to study the kinetics and function of O-linked glycosylation of low density lipoprotein receptors
91. Constitutive and regulated a-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease
92. Release of soluble ICAM-1 from human lung fibroblasts, aortic smooth muscle cells, dermal microvascular endothelial cells, bronchial epithelial cells, and keratinocytes
93. The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis
94. Two different biosynthetic pathways for the secretion of Qa region-associated class I antigens by mouse lymphocytes
95. Membrane-anchored growth factors
96. Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand
97. Potential roles of metalloprotease mediated ectodomain cleavage in signaling by the endothelial receptor tyrosine kinase Tie-1
98. A soluble form of the murine common chain is present at high concentrations in vivo and suppresses cytokine signaling
99. Different proteolytic mechanisms involved in FcγRIIIb shedding from human neutrophils
100. Cleavage and shedding of the TSH receptor
101. Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells
102. Cloning of a disintegrin metalloproteinase that processes precursor tumor-necrosis factor α
103. Receptor-mediated transcellular transport of immunoglobulin: Synthesis of secretory component as multiple and larger transmembrane forms
104. The soluble interleukin-6 receptor is generated by shedding
105. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor
106. Further evidence for a common mechanism for shedding of cell surface proteins
107. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion
108. Soluble forms of the interleukin-6 signal-transducing receptor component gp 130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130
109. Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase
110. Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin)
111. Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis
112. PDGF-α receptor subunit expression down-regulated by IL-1beta in human periodontal ligament cells
113. The transforming receptor tyrosine kinase, Axl, is post-translationally regulated by proteolytic cleavage
114. Nitric oxide enhances expression and shedding of tumor necrosis factor receptor I (p55) in endothelial cells
115. Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts
116. The function of the soluble IL-6 receptor in vivo
117. Furin-dependent intracellular activation of the human stromelysin-3 zymogen
118. Ectodomain cleavage and shedding of the type III transforming growth factor-β receptor in lung membranes effect of temperature, ligand binding and membrane solubilization
119. Cleavage of membrane-bound CD40 ligand is not required for inducing B cell proliferation and differentiation
120. Constitutive shedding of both p55 and p75 murine TNF receptors in vivo
121. Effects of O-linked glycosylation on the cell surface expression and stability of decay-accelerating factor, a glycophospholipid-anchored membrane protein
122. Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1
123. Tumor necrosis factor-α-converting enzyme is required for cleavage of erbB4/HER4
124. Cell volume-dependent regulation of L-selectin shedding in neutrophils. A role for p38 mitogen-activated protein kinase
125. Metalloprotease-disintegrin MDC9: Intracellular maturation and catalytic activity
126. TNF-α-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation
127. The distal ectodomain of angiotensin-converting enzyme regulates its cleavage-secretion from the cell surface
128. Metalloprotease-disintegrins: Modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding
129. Phorbol ester-induced juxtamembrane cleavage of angiotensin-converting enzyme is not inhibited by a stalk containing intrachain disulfides
130. Modulation of juxtamembrane cleavage ('shedding') of angiotensin-converting enzyme by stalk glycosylation: Evidence for an alternative shedding protease
131. Mutational analysis of proprotein processing, subunit association, and shedding of the LAR transmembrane protein tyrosine phosphatase
132. Bacterial/CpG DNA down-modulates colony stimulating factor-1 receptor surface expression on murine bone marrow-derived macrophages with concomitant growth arrest and factor-independent survival
133. Interferon-γ enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins
134. Tyrosine phosphorylation-dependent and -independent associations of protein kinase C-δ with Src family kinases in the RBL-2H3 mast cell line: Regulation of Src family kinase activity by protein kinase C-δ
135. The new enzymology of precursor processing endoproteases
136. Cleavage and shedding of E-cadherin after induction of apoptosis
137. Expression of the receptor-linked protein tyrosine phosphatase LAR: Proteolytic cleavage and shedding of the CAM-like extracellular region
138. Regulated shedding of Syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation
139. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site
140. Processing and juxtacrine activity of membrane-anchored betacellulin
141. Consequences of exclusive expression in vivo of Kit-ligand lacking the major proteolytic cleavage site
142. Down-regulation of Fas ligand by shedding
143. Interleukin-4 (IL-4) induces down-modulation and shedding of the p55 tumour necrosis factor receptor and inhibits TNF α's effect on rheumatoid synovial fibroblasts
144. Role for ADAM-family proteinases as membrane protein secretases
145. A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor
146. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation
147. Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism
148. Tyrosine phosphorylation and proteolysis. Pervanadate-induced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin
149. A role for the immunoglobulin-like domain of the human IL-6 receptor. Intracellular protein transport and shedding
150. A cellular striptease act
151. MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains
152. Soluble E-selectin, other markers of inflammation and disease severity in children with atopic dermatitis
153. A role for MAP kinase in regulating ectodomain shedding of APLP2 in corneal epithelial cells
154. Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble Tie receptor from human endothelial cells via metalloprotease activation
155. In vivo modulation of CD26 (dipeptidyl peptidase IV) in the mouse: Effects of polyreactive and monoreactive antibodies
156. Mechanism of down-regulation of c-kit receptor. Roles of receptor tyrosine kinase, phosphatidylinositol 3'-kinase, and protein kinase C
157. Cross-linking of the human Fc receptor for IgA (FcalphaRI/CD89) triggers FcR γ-chain-dependent shedding of soluble CD89
158. Tumor necrosis factor-α converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: The metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation
159. Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis
160. Heregulin-dependent trafficking and cleavage of ErbB-4
161. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon